- Report
- February 2025
Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France
From €2549EUR$2,850USD£2,207GBP
- Report
- February 2025
United States
From €1297EUR$1,450USD£1,123GBP
- Report
- February 2025
United Kingdom
From €1297EUR$1,450USD£1,123GBP
- Report
- February 2025
France
From €1297EUR$1,450USD£1,123GBP
- Report
- September 2024
- 131 Pages
Global
From €3578EUR$4,000USD£3,098GBP
- Report
- August 2024
- 52 Pages
Global
€15341EUR$17,150USD£13,282GBP
- Report
- March 2024
- 254 Pages
Global
From €2192EUR$2,450USD£1,897GBP
- Report
- July 2023
- 57 Pages
Global
From €8941EUR$9,995USD£7,741GBP
- Report
- July 2023
- 172 Pages
Global
From €4025EUR$4,500USD£3,485GBP
- Report
- September 2021
- 40 Pages
China
From €2326EUR$2,600USD£2,014GBP
- Report
- July 2021
- 50 Pages
China
From €2326EUR$2,600USD£2,014GBP
From €2326EUR$2,600USD£2,014GBP
- Report
- June 2021
- 50 Pages
China
From €2326EUR$2,600USD£2,014GBP
- Report
- April 2021
China
From €2326EUR$2,600USD£2,014GBP
- Report
- April 2021
- 50 Pages
China
From €2326EUR$2,600USD£2,014GBP
- Report
- September 2020
- 40 Pages
China
From €2147EUR$2,400USD£1,859GBP
- Report
- September 2019
- 30 Pages
China
From €1968EUR$2,200USD£1,704GBP
- Report
- October 2018
- 106 Pages
Global
From €2236EUR$2,500USD£1,936GBP
- Drug Pipelines
- January 2018
- 8 Pages
Global
From €8945EUR$10,000USD£7,744GBP
- Report
- December 2022
- 50 Pages
Global
From €1789EUR$2,000USD£1,549GBP

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more